With big pharma signalling interest in novel RNA-targeted approaches, the term “druggable” is being redefined as technology advances.
Some genetic mutations that are expected to completely stop a gene from working surprisingly cause only mild or even no symptoms. Researchers in previous studies have discovered one reason why: cells ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results